CompoAtlas

Blink Nutritears

Natural health product licensed in Canada

Other names
Nutritears, Nutritears Lutein CD OS 3%, VisionBlend, Visionvitalize
Licence holder
Bausch & Lomb Inc.
NPN or DIN-HM
80131868
Status
Active licence
Licence date
14 June 2024
Revision date
4 September 2026
Form
Capsule, molle
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Tagetes erecta

Source : Tagetes erecta - Fleur

Potency : 1.6 mg Zeaxanthin

40 mgNot calculated
Tagetes erecta

Source : Tagetes erecta - Fleur

Potency : 20 mg Lutein

Not specifiedNot calculated
Vitamine D

Source : Cholécalciférol

15 microgram15 µg
Vitamine D

Source : Cholécalciférol

600 UI15 µg
Curcuminoïdes

Source : Curcuma longa - rhizome

Potency : 70 % Curcumin

200 mgNot calculated

Non-medicinal ingredients

Gélatine, Sorbitol, Huile d'olive, Hydrolysat d'amidon hydrogéné, NA, Eau, d-limonène, Huile de lin, Sorbitan, Mélange de concentré de tocophérols, Oxyde de Fer Rouge, Huile de thym, Lécithine, Glycérine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in improving tear production in persons with Dry Eye Syndrome. Helps improve symptoms of Dry Eye Syndrome. Supports proper tear function (decreased rate of tear evaporation and increase in tear secretion) in persons with Dry Eye Syndrome. Helps to support tear stability, increase tear secretion and decrease the rate of tear evaporation in persons with Dry Eye Syndrome. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80131868

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line